Clarity on whether any one-time revenue was booked in Q1 and the outlook for consumer segment revenues over the next three quarters.

Mr. Gujral categorically denied any one-time transaction; the performance was driven by high-margin exports and ODM. Consumer segment will remain around 30% on an annual basis, though quarter-to-quarter mix can vary.

Update on the entry into renewable energy (inverter) space post decoupling from the KSolare deal.

Management stated they are in negotiation with potential partners and it remains a focus area, but nothing concrete to report; will update the street once a firm tie-up is in place.

Risk to achieving FY27 guidance from supply chain disruptions, especially the PCB shortage.

Mr. Gujral said that on a micro level, demand and execution strategy pose no risk; the only imponderable is the geopolitical situation in West Asia. A dedicated war room is managing critical shortages, and they expect to achieve or exceed guidance barring further escalation.

Details behind the Board resolution to raise up to ₹1,000 Cr via QIP.

Management clarified it is an enabling resolution taken annually to have a war chest ready for emerging opportunities in semiconductors or other areas; there is no immediate fundraising need.

Syrma SGS Tech. Q1 FY27 Earnings Call — Analysis (NSE: SYRMA)

Syrma SGS delivers a 67% YoY revenue surge and 112% PAT jump in Q1FY27, driven by exports (+61% YoY) and ODM doubling YoY, with management confident of exceeding full-year guidance.

4 Aug 2026 · Analysis by Alpha Inflection

The take

Q1FY27 Consolidated Total Revenue ₹1,604 Cr ( +67% YoY ) . New guidance — FY27 fy27 revenue growth exceed 35%+ . New story: Export-led diversification .

Results

Revenue ₹1,604 Cr +67% YoY; Operating EBITDA ₹162 Cr +69% YoY; PAT ₹106 Cr +112% YoY; exports 24% of revenue, ODM 17%.

Financial highlights

Syrma SGS Tech. Q1 FY27 reported figures
Metric	Value	Change	Basis
Consolidated Total Revenue	₹1,604 Cr	+67%	yoy · Q1FY27
Operating EBITDA	₹162 Cr	+69%	yoy · Q1FY27
Total EBITDA (incl other income)	₹177 Cr	+72%	yoy · Q1FY27
Profit Before Tax	₹141 Cr	+~110%	yoy · Q1FY27
Profit After Tax	₹106 Cr	+112%	yoy · Q1FY27
Export Revenue	₹387 Cr	+61%	yoy · Q1FY27 · 24% of total revenue
ODM Revenue	₹270 Cr	+~115%	yoy · Q1FY27 · 17% of total revenue
Total Order Book	₹6,770 Cr	+na	point_in_time · point_in_time · As on Jun-26
Net Cash Position	₹122 Cr	+na	point_in_time · point_in_time · As on Jun-26
Net Working Capital Days	71 days	+8 days	sequential · Q1FY27 · vs Q4FY26
Adjusted Annualized ROCE	20.1%	+na	none · Q1FY27

Guidance

Management expects to exceed FY27 guidance of 35%+ revenue growth and 10.5-11% EBITDA margin, supported by strong Q1 and order book visibility.

What management committed to

We are confident of achieving and exceeding the [FY27 revenue growth guidance of 35%+]. — exceed 35%+, FY27
We maintain 10.5% to 11% operating EBITDA margin for [FY27] full year. — 10.5% to 11%, FY27
Export revenue for [FY27] should grow around 30% to 40%, reaching ₹1,500 crore to ₹1,600 crore. — ₹1,500 Cr to ₹1,600 Cr, FY27
PCB project will start commercial production by April 2027. — Q4FY27
We will power on the equipment in the [PCB project] between January and March 2027, then take out samples and start client approval process. — Q4FY27
At full ramp-up, the [PCB project] can deliver 1.5x asset turns and EBITDA margin of 15–18% excluding any PLI incentive. — 1.5x asset turns; 15–18% EBITDA margin, at full ramp-up
The [Kaga JV] business can reach ₹300 crore to ₹500 crore over the next 3–5 years. — ₹300 Cr to ₹500 Cr, FY31
Defense portfolio will continue to grow at 30–35% annually going forward. — 30% to 35%, going forward
[Syrma Johari MedTech subsidiary] business should grow almost 50% in FY27. — almost 50%, FY27
Capex excluding PCB project is expected to be ₹100 crore to ₹150 crore in FY27. — ₹100 Cr to ₹150 Cr, FY27
The [18 new] customer additions [in Q1FY27] may have potential to give ₹1,000 crore plus kind of revenue on a full ramp-up basis. — ₹1,000 Cr +, full ramp-up basis
We will be able to grow at this percentage [30–35% CAGR] for at least the next two to three years (FY28 and FY29). — 30% to 35%, FY29

Key themes

Export-led growth and ODM ramp-up underpin confidence

How the narrative shifted

Export-led diversification: Exports grew 61% YoY; management frames it as a structural pivot that integrates Syrma into global supply chains, driven by the China+1 trend and diversification of electronics sourcing.
ODM margin uplift: ODM revenue doubled YoY to 17% of sales, long-term target 25%, positioned as a higher-margin, design-led business that improves overall profitability and competitive differentiation.
Supply chain headwinds: Geopolitical tensions and component shortages are causing lead-time expansion and forcing strategic inventory build, described as a managed challenge with a dedicated 'war room' and temporary working capital impact.
PCB vertical integration: The PCB project is on track for April 2027 commercial start, with Phase 1 capex of ₹400 Cr, expected asset turns of 1.5x and EBITDA of 15-18% ex incentives, seen as reducing import dependence and strengthening supply chain control.
Capital discipline / Semicon caution: Management signals interest in semiconductor ecosystem but insists on a credible partner; QIP resolution is only an enabling step; JV criteria are technology, market access, or regulatory approvals.
New CEO strategic renewal: Jaidit Brar, ex-McKinsey, joins as CEO, bringing a 360-degree strategic lens; management expects this will help Syrma move beyond production-led manufacturing to a more comprehensive, design-led approach.
Broad-based vertical growth: All verticals are expanding, with auto (EV) and healthcare leading; consumer mix will revert to ~30% annually despite quarterly spikes; industrial growth temporarily muted by defense seasonality and smart-meter caution.
Long-term institution building: Management repeatedly emphasizes building a multi-decade institution with relentless focus on design/engineering, free cash flows, and disciplined capital allocation, discouraging quarterly myopia.

Operational commentary

Formed JV with Japanese MNC Kaga (Syrma 60%) to manufacture all Kaga EMS requirements in India; initial investment ~₹24-25 Cr; long-term revenue potential ₹300-500 Cr over 3-5 years.
PCB project on track: building 65-70% complete, equipment arriving from Oct, power-on expected Jan-Mar'27, commercial production targeted Apr'27; Phase 1 capex ₹400 Cr, funded via internal accruals, debt, and 50% govt capex incentive.
Onboarded 18 new clients during the quarter (5 auto, 3 industrial, 2 healthcare, rest IT/railways/telecom); full ramp-up potential of ₹1,000 Cr+ additional revenue over the next few years.
Exports grew 61% YoY to ₹387 Cr (24% of revenue), driven by industrial, MedTech, and auto; Europe 40%, US 22%, North America total ~37% of exports; management sees export as a structural growth pillar.
ODM revenue doubled YoY to ₹270 Cr (17% of sales); long-term target to reach 25% of revenue; currently led by healthcare, defense, consumer, and industrial.
Supply chain constraints from geopolitical issues in Middle East leading to component shortages; company established a dedicated 'war room' and is treating inventory as a strategic asset, resulting in higher working capital days (71) and ₹340 Cr increase in short-term borrowings.
Capacity expansion underway: MedTech facility in Jodhpur adding medical-grade plastic injection molding and SMT lines; Bangalore facility being expanded for data center power management/cooling systems; Pune capacity also being enhanced.
Healthcare segment (incl. MedTech) gaining traction; MedTech subsidiary Syrma Johari MedTech targeting ~50% growth in FY27 on a base of ₹210 Cr in FY26; two new healthcare clients onboarded for CDMO and design.
Automotive business strong (25% of revenue) driven by EV adoption and charging infrastructure; consumer mix expected to remain ~30% annually despite Q1 spike to 34%; industrial segment saw sequential moderation due to rear-ended maritime defense schedules and slow smart metering.
New CEO Jaidit Brar (ex-McKinsey, 24 yrs) joined 29-Jun-26 to bring strategic breadth; management reiterates interest in ISM 2.0 semiconductor opportunities but only with a credible partner.

Analyst Q&A

Q. Clarity on whether any one-time revenue was booked in Q1 and the outlook for consumer segment revenues over the next three quarters.
Mr. Gujral categorically denied any one-time transaction; the performance was driven by high-margin exports and ODM. Consumer segment will remain around 30% on an annual basis, though quarter-to-quarter mix can vary.
Q. Update on the entry into renewable energy (inverter) space post decoupling from the KSolare deal.
Management stated they are in negotiation with potential partners and it remains a focus area, but nothing concrete to report; will update the street once a firm tie-up is in place.
Q. Risk to achieving FY27 guidance from supply chain disruptions, especially the PCB shortage.
Mr. Gujral said that on a micro level, demand and execution strategy pose no risk; the only imponderable is the geopolitical situation in West Asia. A dedicated war room is managing critical shortages, and they expect to achieve or exceed guidance barring further escalation.
Q. Details behind the Board resolution to raise up to ₹1,000 Cr via QIP.
Management clarified it is an enabling resolution taken annually to have a war chest ready for emerging opportunities in semiconductors or other areas; there is no immediate fundraising need.

View source

Research and educational content only. Not investment advice.